INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.50, sa.8, ss.1367-1373, 2018 (SCI-Expanded)
We aimed to evaluate the efficacy and safety of intravesical onabotulinum toxin A (onaBoNTA) injections for the treatment of children diagnosed with refractory overactive bladder (OAB) by using non-invasive methods.